Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...
There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or immunohistochemistry, Robert Kratzke, MD, says. Delays in genomic testing continue ...
Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care. Vivek Subbiah, MD, chief ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
We conducted a retrospective cohort study of stage IV NSCLC patients, with Tempus xT tissue-based sequencing. Adherence to NCCN-recommended therapy was defined as the proportion of patients who ...
Affinity leans on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health expands liquid biopsy ...
A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people each year. The test, known as a liquid biopsy, is designed to speed up access ...
NORFOLK, Va. — A new report from the American Lung Association shows that Virginia is making measurable progress in the fight against lung cancer, but the state still lags behind in early detection, ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results